Previous studies showed that serum levels of FGF21 are significantly increased in both AKI and CKD, and FGF21 concentration is correlated with the severity of kidney injury (Li F. et al., 2018; Suassuna et al., 2019). This evidence concerns the gene FGF21 and chronic kidney disease.